Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Endoscopic papillectomy for ampullary lesions in patients with familial adenomatous polyposis compared with sporadic lesions: A propensity score-matched cohort

Vu Trung, K. ; Regner, S. LU orcid and Hollenbach, Marcus (2022) In Endoscopy 55(8). p.709-718
Abstract
Background Familial adenomatous polyposis (FAP) is a rare inherited syndrome that predisposes the patient to cancer. Treatment of FAP-related ampullary lesions is challenging and the role of endoscopic papillectomy has not been elucidated. We retrospectively analyzed the outcomes of endoscopic papillectomy in matched cohorts of FAPrelated and sporadic ampullary lesions (SALs). Methods This retrospective multicenter study included 1422 endoscopic papillectomy procedures. Propensity score matching including age, sex, comorbidity, histologic subtype, and size was performed. Main outcomes were complete resection (R0), technical success, complications, and recurrence. Results Propensity score matching identified 202 patients (101 FAP, 101 SAL)... (More)
Background Familial adenomatous polyposis (FAP) is a rare inherited syndrome that predisposes the patient to cancer. Treatment of FAP-related ampullary lesions is challenging and the role of endoscopic papillectomy has not been elucidated. We retrospectively analyzed the outcomes of endoscopic papillectomy in matched cohorts of FAPrelated and sporadic ampullary lesions (SALs). Methods This retrospective multicenter study included 1422 endoscopic papillectomy procedures. Propensity score matching including age, sex, comorbidity, histologic subtype, and size was performed. Main outcomes were complete resection (R0), technical success, complications, and recurrence. Results Propensity score matching identified 202 patients (101 FAP, 101 SAL) with comparable baseline characteristics. FAP patients were mainly asymptomatic (79.2% [95 %CI 71.2-87.3] vs. 46.5% [95 %CI 36.6-56.4]); P < 0.001). The initial R0 rate was significantly lower in FAP patients (63.4% [95%CI 53.8-72.9] vs. 83.2% [95%CI 75.8-90.6]; P = 0.001). After repeated interventions (mean 1.30 per patient), R0 was comparable (FAP 93.1% [95%CI 88.0-98.1] vs. SAL 97.0% [95%CI 93.7-100]; P = 0.19). Adverse events occurred in 28.7%. Pancreatitis and bleeding were the most common adverse events in both groups. Severe adverse events were rare (3.5 %). Overall, 21 FAP patients (20.8% [95%CI 12.7-28.8]) and 16 SAL patients (15.8% [95%CI 8.6-23.1]; P = 0.36) had recurrence. Recurrences occurred later in FAP patients (25 [95 %CI 18.3-31.7] vs. 2 [95 %CI CI 0.06-3.9] months). Conclusions Endoscopic papillectomy was safe and effective in FAP-related ampullary lesions. Criteria for endoscopic resection of ampullary lesions can be extended to FAP patients. FAP patients have a lifetime risk of relapse even after complete resection, and require long-time surveillance. © 2022 Georg Thieme Verlag. All rights reserved. (Less)
Please use this url to cite or link to this publication:
author
; and
author collaboration
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Adenomatous Polyposis Coli, Ampulla of Vater, Common Bile Duct Neoplasms, Humans, Neoplasm Recurrence, Local, Propensity Score, Retrospective Studies, Treatment Outcome, ablation therapy, adult, adverse event, aged, American Society of Anaesthesiologists score, ampullectomy, Article, bile duct dilatation, cardiovascular disease, cholangitis, clinical feature, clinical outcome, cohort analysis, comorbidity, conscious sedation, controlled study, disease free survival, duodenum injury, en bloc resection, endoscopic papillotomy, endoscopic retrograde cholangiopancreatography, endoscopic surgery, familial adenomatous polyposis, female, follow up, general anesthesia, histology, human, human tissue, laboratory test, length of stay, lifetime risk, major clinical study, male, overall survival, pancreaticoduodenectomy, pancreatitis, perforation, postoperative complication, postoperative hemorrhage, propensity score, radiofrequency ablation, recurrent disease, retrospective study, sporadic ampullary lesion, Vater papilla tumor, ampulla of Vater, bile duct tumor, clinical trial, colon polyposis, multicenter study, pathology, treatment outcome, tumor recurrence
in
Endoscopy
volume
55
issue
8
pages
10 pages
publisher
Georg Thieme Verlag
external identifiers
  • scopus:85166364173
ISSN
0013-726X
DOI
10.1055/a-2029-2935
language
English
LU publication?
yes
id
f5c84b67-6a12-4005-b3a2-e03d2c31ac22
date added to LUP
2023-12-22 15:22:09
date last changed
2024-01-08 14:56:30
@article{f5c84b67-6a12-4005-b3a2-e03d2c31ac22,
  abstract     = {{Background Familial adenomatous polyposis (FAP) is a rare inherited syndrome that predisposes the patient to cancer. Treatment of FAP-related ampullary lesions is challenging and the role of endoscopic papillectomy has not been elucidated. We retrospectively analyzed the outcomes of endoscopic papillectomy in matched cohorts of FAPrelated and sporadic ampullary lesions (SALs). Methods This retrospective multicenter study included 1422 endoscopic papillectomy procedures. Propensity score matching including age, sex, comorbidity, histologic subtype, and size was performed. Main outcomes were complete resection (R0), technical success, complications, and recurrence. Results Propensity score matching identified 202 patients (101 FAP, 101 SAL) with comparable baseline characteristics. FAP patients were mainly asymptomatic (79.2% [95 %CI 71.2-87.3] vs. 46.5% [95 %CI 36.6-56.4]); P &lt; 0.001). The initial R0 rate was significantly lower in FAP patients (63.4% [95%CI 53.8-72.9] vs. 83.2% [95%CI 75.8-90.6]; P = 0.001). After repeated interventions (mean 1.30 per patient), R0 was comparable (FAP 93.1% [95%CI 88.0-98.1] vs. SAL 97.0% [95%CI 93.7-100]; P = 0.19). Adverse events occurred in 28.7%. Pancreatitis and bleeding were the most common adverse events in both groups. Severe adverse events were rare (3.5 %). Overall, 21 FAP patients (20.8% [95%CI 12.7-28.8]) and 16 SAL patients (15.8% [95%CI 8.6-23.1]; P = 0.36) had recurrence. Recurrences occurred later in FAP patients (25 [95 %CI 18.3-31.7] vs. 2 [95 %CI CI 0.06-3.9] months). Conclusions Endoscopic papillectomy was safe and effective in FAP-related ampullary lesions. Criteria for endoscopic resection of ampullary lesions can be extended to FAP patients. FAP patients have a lifetime risk of relapse even after complete resection, and require long-time surveillance. © 2022 Georg Thieme Verlag. All rights reserved.}},
  author       = {{Vu Trung, K. and Regner, S. and Hollenbach, Marcus}},
  issn         = {{0013-726X}},
  keywords     = {{Adenomatous Polyposis Coli; Ampulla of Vater; Common Bile Duct Neoplasms; Humans; Neoplasm Recurrence, Local; Propensity Score; Retrospective Studies; Treatment Outcome; ablation therapy; adult; adverse event; aged; American Society of Anaesthesiologists score; ampullectomy; Article; bile duct dilatation; cardiovascular disease; cholangitis; clinical feature; clinical outcome; cohort analysis; comorbidity; conscious sedation; controlled study; disease free survival; duodenum injury; en bloc resection; endoscopic papillotomy; endoscopic retrograde cholangiopancreatography; endoscopic surgery; familial adenomatous polyposis; female; follow up; general anesthesia; histology; human; human tissue; laboratory test; length of stay; lifetime risk; major clinical study; male; overall survival; pancreaticoduodenectomy; pancreatitis; perforation; postoperative complication; postoperative hemorrhage; propensity score; radiofrequency ablation; recurrent disease; retrospective study; sporadic ampullary lesion; Vater papilla tumor; ampulla of Vater; bile duct tumor; clinical trial; colon polyposis; multicenter study; pathology; treatment outcome; tumor recurrence}},
  language     = {{eng}},
  number       = {{8}},
  pages        = {{709--718}},
  publisher    = {{Georg Thieme Verlag}},
  series       = {{Endoscopy}},
  title        = {{Endoscopic papillectomy for ampullary lesions in patients with familial adenomatous polyposis compared with sporadic lesions: A propensity score-matched cohort}},
  url          = {{http://dx.doi.org/10.1055/a-2029-2935}},
  doi          = {{10.1055/a-2029-2935}},
  volume       = {{55}},
  year         = {{2022}},
}